Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck

Clinical trial NCT02499328 · COMPLETED

Trial details

NCT number: NCT02499328
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck

Start date: 2015-08-06
Primary completion: 2020-02-28
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.